{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 AST Streptococcus Vancomycin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K121100",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 8, 2012",
    "Summary Letter Received Date": "November 9, 2012",
    "Submission Date": "April 5, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Vancomycin"
    ],
    "Specimen Type(s)": [
        "Streptococcus species isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "MIC microdilution methodology",
        "Automated incubation and reading"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated susceptibility testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Card"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 AST Streptococcus Vancomycin antimicrobial susceptibility test using microdilution methodology on VITEK 2 automated platforms",
    "Indications for Use Summary": "Designed for antimicrobial susceptibility testing of Streptococcus species to determine in vitro susceptibility to vancomycin using the VITEK 2 and VITEK 2 Compact Systems",
    "fda_folder": "Microbiology"
}